BioStock: Cereno Scientific reaches milestone with CS014

Cereno Scientific has announced that new data generated from the preclinical CS014 programme has triggered a milestone payment to Emeriti Bio and led to a new patent application being filed. The news signals significant progress for this programme, which is aimed at developing new and better treatments for cardiovascular disease.

Read the article at biostock.se:

https://www.biostock.se/en/2022/02/cereno-scientific-reaches-milestone-with-cs014/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se